BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6800051)

  • 1. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
    Tran TH; Marbet GA; Duckert F
    Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to human procoagulant factor VIII.
    Rotblat F; Goodall AH; O'Brien DP; Rawlings E; Middleton S; Tuddenham EG
    J Lab Clin Med; 1983 May; 101(5):736-46. PubMed ID: 6403638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
    Tran TH; Duckert F
    Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on human factor VIII and its antibodies using radiolabelling and affinity chromatography.
    Kavanagh ML; Wood CN; Davidson JF
    Thromb Haemost; 1981 Jun; 45(3):267-71. PubMed ID: 6792739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired haemophilia: functional study of antibodies to Factor VIII.
    Allain JP; Gaillandre A; Frommel D
    Thromb Haemost; 1981 Jun; 45(3):285-9. PubMed ID: 6792741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The properties of immune complexes formed by human antibodies to factor VIII.
    Lazarchick J; Hoyer LW
    J Clin Invest; 1977 Nov; 60(5):1070-9. PubMed ID: 908750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
    Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on a monoclonal antibody to human factor viii coagulant activity, with a description of a facile two-site factor VIII coagulant antigen assay.
    Brown JE; Thuy LP; Carton CL; Hougie C
    J Lab Clin Med; 1983 May; 101(5):793-805. PubMed ID: 6403639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acquired hemophilia A due to factor VIIIC inhibitor: detection of circulating immune complexes containing factor VIIIC but not factor VIIIR].
    Pfyffer M; Kistler HJ; von Felten A
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1456-9. PubMed ID: 6417777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of human factor VIII. I. Characterization of factor VIII present in the supernatant of cryoprecipitate.
    Over J; Bouma BN; van Mourik JA; Sixma JJ; Vlooswijk R; Bakker-Woudenberg I
    J Lab Clin Med; 1978 Jan; 91(1):32-46. PubMed ID: 618989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of naturally occurring antibodies to factor VIII on an immunoradiometric assay for factor VIII coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIII inhibit.
    Brown JE; Carton CL; Hougie C
    J Lab Clin Med; 1981 Jan; 97(1):65-71. PubMed ID: 6778942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
    Hoyer LW; Trabold NC
    J Lab Clin Med; 1981 Jan; 97(1):50-64. PubMed ID: 6778941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the neutralization of rabbit antibodies to human factor VIII.
    Kernoff PB; Kaelin AC
    Thromb Haemost; 1977 Oct; 38(3):707-16. PubMed ID: 74103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factor VIII complex activities in acute leukemia].
    Pniejnia-OlszyƄski W; Lopaciuk S
    Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability.
    Verbruggen B; Novakova I; Wessels H; Boezeman J; van den Berg M; Mauser-Bunschoten E
    Thromb Haemost; 1995 Feb; 73(2):247-51. PubMed ID: 7792738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological evidence that human factor VIII is composed of two linked moieties.
    Koutts J; Lavergne JM; Meyer D
    Br J Haematol; 1977 Nov; 37(3):415-28. PubMed ID: 341960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding to phospholipid protects factor VIII from inactivation by human antibodies.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    J Lab Clin Med; 1983 Jan; 101(1):34-43. PubMed ID: 6401316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dissociation of human factor VIII and recombination of the fragments VIII-C and VIII-AG].
    Tran TH; Bounameaux H; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1979 Jul; 109(28):1029-34. PubMed ID: 462170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
    Kirby EP
    Thromb Haemost; 1981 Aug; 46(2):479-84. PubMed ID: 6795738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of anti-human and anti-porcine factor VIII antibody titers in patients with hemophilia].
    Windyga J; Rzymkiewicz L; Lopaciuk S
    Acta Haematol Pol; 1996; 27(1):27-31. PubMed ID: 8629440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.